LAKE FOREST, Ill., Nov. 11, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has been selected as one of the Chicago Tribune's 2016 Top Midsize Workplaces. "It is a great honor to be recognized by the Chicago Tribune as a top workplace for the second year in a row," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. "At Horizon, our culture is the backbone of our company. This award is special because it is based on responses from the people who live and breathe our culture everyday - our employees. The connections we have to each other and the work we do on behalf of patients is at the very core of what makes Horizon a truly unique place to work." The Chicago Tribune Top Workplaces award recognizes Chicago-area organizations that have created exceptional work environments and is based solely on results from an employee feedback survey. WorkplaceDynamics, LLC, a leading research firm specializing in organizational health and improvement, administered the survey which measured several aspects of workplace culture, including alignment, execution and connection. About Horizon Pharma plc Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. Horizon Pharma markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.